financetom
Business
financetom
/
Business
/
Update: Marimaca Copper Provides Definitive Feasibility Results for Namesake Deposit in Chile
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: Marimaca Copper Provides Definitive Feasibility Results for Namesake Deposit in Chile
Aug 26, 2025 8:52 AM

11:16 AM EDT, 08/26/2025 (MT Newswires) -- (Adds investment bank comment and updates shares.)

Marimaca Copper ( MARIF ) reported overnight Monday the results of a definitive feasibility study for its Marimaca oxide deposit in Chile.

The study outlined a post-tax net present value of US$709 million based on an 8% discount rate, with a 31% internal rate of return and a 2.5-year payback period. Initial capital costs were estimated at US$587 million.

The project is expected to produce 43,000 tonnes per year of copper over the 13-year life of mine.

The study also outlined maiden proven and probable reserves for the project, estimating 178.6 million tonnes with an average grade of 0.42% total copper for 750,000 of contained copper.

"There are very few copper projects with lower capital intensity, and our competitive operating cost profile, positioned in the second quartile of Wood Mackenzie-benchmarked copper projects globally on an all-in-cost basis, drives superior return on invested capital metrics at virtually any copper price," chief executive Hayden Locke said.

Marimaca said its debt financing workstreams are underway, aiming to identify preferred financing partners by year-end.

National Bank of Canada maintained its outperform rating and $11.00 price target following the release.

The bank said the outperform rating is supported by Marimaca's peer-leading capital intensity, aided by near-surface oxides resulting in low life of mine strip and proximity to existing infrastructure.

National Bank also sees further upside at Pampa Medina from the ongoing drill program, which expands the size of the defined area where they see high-grade mineralization.

Marimaca shares were last seen down $1.38 to $10.06 on the Toronto Stock Exchange.

Price: 10.10, Change: -1.34, Percent Change: -11.71

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Burke & Herbert Financial Services Completes Merger With Summit Financial Group
Burke & Herbert Financial Services Completes Merger With Summit Financial Group
May 3, 2024
11:16 AM EDT, 05/03/2024 (MT Newswires) -- Burke & Herbert Financial Services (BHRB) said Friday it has completed its merger of equals with Summit Financial Group ( SMMF ) . Under the terms of the transaction, Summit Financial ( SMMF ) has merged with and into Burke & Herbert while Summit Community Bank has merged with and into Burke &...
Correction: Market Chatter: DOJ Probe Into TD Bank Linked to Laundering of Fentanyl Profits
Correction: Market Chatter: DOJ Probe Into TD Bank Linked to Laundering of Fentanyl Profits
May 3, 2024
11:22 AM EDT, 05/03/2024 (MT Newswires) -- (Corrects the headline to indicate the probe is related to laundering fentanyl profits.) The US Department of Justice investigation into Toronto-Dominion Bank's ( MLWIQXX ) internal controls is focused on how Chinese drug traffickers used the company to launder US fentanyl sales revenue, The Wall Street Journal reported Friday. (Market Chatter news is...
Drugmaker Amneal agrees to $270 million U.S. opioid settlement
Drugmaker Amneal agrees to $270 million U.S. opioid settlement
May 3, 2024
(Reuters) - Amneal Pharmaceuticals ( AMRX ) said on Friday it had reached a deal valued at more than $270 million to resolve claims it helped fuel the deadly U.S. opioid epidemic, becoming the latest drug company to settle lawsuits over the addiction crisis brought by states and local governments. Amneal reached an agreement in principle to pay $92.5 million...
Abeona Therapeutics Prices $75 Million Securities Offering; Shares Rise
Abeona Therapeutics Prices $75 Million Securities Offering; Shares Rise
May 3, 2024
11:19 AM EDT, 05/03/2024 (MT Newswires) -- Abeona Therapeutics ( ABEO ) said Friday it is selling about 12.3 million shares at $4.07 per share and, in lieu of stock, pre-funded warrants to buy some 6.1 million shares at $4.0699 per warrant to raise about $75 million in an underwritten offering. The pre-funded warrants will be immediately exercisable, the company...
Copyright 2023-2026 - www.financetom.com All Rights Reserved